Yahoo! News: Weight Loss News

---

• FDA rejects Orexigen's weight-loss drug Contrave (AFP)
• U.S. rejects Orexigen diet drug over heart risks (Reuters)
• Bariatric surgery cuts pounds, adds years (Reuters)

FDA rejects Orexigen's weight-loss drug Contrave (AFP) Posted: 01 Feb 2011 06:51 AM PST AFP - The US Food and Drug Administration on Tuesday declined to approve a weight loss drug by the California pharmaceutical company Orexigen, saying it must conduct more studies to rule out heart risks.

U.S. rejects Orexigen diet drug over heart risks (Reuters) Posted: 01 Feb 2011 04:54 AM PST Reuters - U.S. health regulators rejected Orexigen Therapeutics Inc's weight-loss drug and requested a clinical trial to resolve heart safety concerns, dealing a huge blow to what stood to be the first new diet pill in a decade.

Bariatric surgery cuts pounds, adds years (Reuters) Posted: 31 Jan 2011 01:35 PM PST Reuters - Obese individuals may add years to their lives by drastically cutting pounds with bariatric surgery, according to a new review of clinical trials of popular gastric bypass and banding procedures.

You are subscribed to email updates from Yahoo! News: Weight Loss News To stop receiving these emails, you may unsubscribe now.	Email delivery powered by Google
Google Inc., 20 West Kinzie, Chicago IL USA 60610